-
EP1920767
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1920767
| EP1920767 - Melt-processed imatinib dosage form [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 24.04.2009 Database last updated on 11.05.2024 | Most recent event Tooltip | 24.04.2009 | Application deemed to be withdrawn | published on 27.05.2009 [2009/22] | Applicant(s) | For all designated states Abbott GmbH & Co. KG Max-Planck-Ring 2 65205 Wiesbaden / DE | For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH | [N/P] |
| Former [2008/20] | For all designated states Abbott GmbH & Co. KG Max-Planck-Ring 2 65205 Wiesbaden / DE | ||
| For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH | Inventor(s) | 01 /
Breitenbach, Jörg Hans-Sachs-Ring 95 a 68199 Mannheim / DE | 02 /
Steiger, Norbert Druslachstr. 1 67360 Lingenfeld / DE | 03 /
Hach, Harald Weissenburgerstr. 2 76889 Oberotterbach / DE | 04 /
Westedt, Ulrich Weinheimerstr. 2 69198 Schriesheim / DE | 05 /
Knobloch, Martin Medenheimerstr. 22a 67141 Neuhofen / DE | 06 /
Altenburger, Ralf Muelheweg 9 79591 Eimeldingen / DE | 07 /
Loggia, Nicoletta Schorenweg 32 4058 Basel / CH | 08 /
Ogorka, Jörg Im Steinbrunnen 19/3 79585 Steinen / DE | [2008/20] | Representative(s) | Reitstötter Kinzebach Patentanwälte Sternwartstraße 4 81679 München / DE | [N/P] |
| Former [2008/20] | Reitstötter - Kinzebach Patentanwälte Sternwartstrasse 4 81679 München / DE | Application number, filing date | 06023367.3 | 09.11.2006 | [2008/20] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP1920767 | Date: | 14.05.2008 | Language: | EN | [2008/20] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 09.08.2007 | Classification | IPC: | A61K9/20, A61K31/505 | [2008/20] | CPC: |
A61K9/2095 (EP,US);
A61K9/2054 (EP,US);
A61P35/00 (EP);
A61P35/02 (EP)
| Designated contracting states | [2009/04] |
| Former [2008/20] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR | Title | German: | Schmelzverarbeitete Darreichungsform mit Imatinib | [2008/20] | English: | Melt-processed imatinib dosage form | [2008/20] | French: | Forme posologique d'Imatinib préparée à l'état fondu. | [2008/20] | Examination procedure | 15.11.2008 | Application deemed to be withdrawn, date of legal effect [2009/22] | 29.12.2008 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2009/22] | Fees paid | Penalty fee | Additional fee for renewal fee | 30.11.2008 | 03 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XD]WO9903854 (NOVARTIS AG [CH], et al) [XD] 1-12 * page 17, line 25; example 4; claims 11,12 *; | [AD]WO03090720 (NOVARTIS AG [CH], et al) [AD] 1 * page 3, paragraph 4; claims 1-15 *; | [A]WO2006040779 (NATCO PHARMA LTD [IN], et al) [A] 1 * page 11, lines 4-9; claim 13 *; | [X]WO2006054314 (NATCO PHARMA LTD [IN], et al) [X] 1-12 * examples 7,8; claims 1,7 *; | [L]WO2006121941 (NOVARTIS AG [CH], et al) [L] 1 * page 11, paragraph 2; claim 14 *; | [A] - H. MOLLET ET AL., Formulation technology. Emulsions, suspensions, solid forms, WILEY VCH, (2001), XP002445079 [A] 1 * page 70 - page 73 * * page 103 * |